Pancreatic Insufficiency Clinical Trials

• A Open-Label Study to Assess the Safety of Oral Long-Term Use of SA-001 in Pancreatic Exocrine Insufficiency
  ClinicalTrials.gov Identifier: NCT00401076 - Recruiting
  Pancreatic Exocrine Insufficiency; Chronic Pancreatitis; Pancreatectomy
  
• A Study to Evaluate the Safety and Efficacy of Eurand Pancreatic Enzyme Product (PEP) in Patients With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
  ClinicalTrials.gov Identifier: NCT00297167 - Recruiting
  Cystic Fibrosis; Exocrine Pancreatic Insufficiency
  
• A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency
  ClinicalTrials.gov Identifier: NCT00400842 - Recruiting
  Exocrine Pancreatic Insufficiency; Chronic Pancreatitis
  
• Efficacy and Safety of ULTRASE MT20 in Improving the Coefficient of Fat Absorption (CFA%) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)
  ClinicalTrials.gov Identifier: NCT00513682 - Recruiting
  Cystic Fibrosis; Pancreatic Insufficiency
  
• ALTU-135 Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
  ClinicalTrials.gov Identifier: NCT00449878 - Recruiting
  Cystic Fibrosis; Exocrine Pancreatic Insufficiency
  
• Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
  ClinicalTrials.gov Identifier: NCT00001223 - Recruiting
  Bronchiectasis; Cystic Fibrosis; Pancreatic Insufficiency
  
• A Study Investigating Pancrelipase Delayed Release Capsules in Patients With Exocrine Pancreatic Insufficiency
  ClinicalTrials.gov Identifier: NCT00414908 - Suspended
  Pancreatic Insufficiency
  
• Creon After Pancreatic Surgery
  ClinicalTrials.gov Identifier: NCT00535756 - Not yet recruiting
  Pancreatic Insufficiency
  
• Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects with Exocrine Pancreatic Insufficiency
  ClinicalTrials.gov Identifier: NCT00095732 - Completed
  Cystic Fibrosis; Pancreatic Insufficiency
  
• A Safety and Efficacy Study on ULTRASE MT20 in Patients With Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (PI)
  ClinicalTrials.gov Identifier: NCT00408317 - Completed
  Cystic Fibrosis; Exocrine Pancreatic Insufficiency
  
• Phase III ALTU-135 CP Safety Trial
  ClinicalTrials.gov Identifier: NCT00500084 - Recruiting
  Pancreatic Insufficiency
  
• Malabsorption Blood Test:Toward a Novel Approach to Quantify Steatorrhea
  ClinicalTrials.gov Identifier: NCT00572975 - Recruiting
  Cystic Fibrosis; Pancreatic Insufficiency
  
• Phase III ALTU-135 Safety Trial
  ClinicalTrials.gov Identifier: NCT00449904 - Recruiting
  Cystic Fibrosis; Exocrine Pancreatic Insufficiency
  
• Safety and Efficacy Study of VIOKASE 16 for the Correction of Steatorrhea
  ClinicalTrials.gov Identifier: NCT00559364 - Recruiting
  Exocrine Pancreatic Insufficiency; Chronic Pancreatitis
  
• 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00064051 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PI
  ClinicalTrials.gov Identifier: NCT00406536 - Recruiting
  Cystic Fibrosis; Pancreatic Insufficiency
  
• Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005869 - Active, not recruiting
  recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
  
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00004003 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without R115777 in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005648 - Active, not recruiting
  recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
  
• Paclitaxel and Bryostatin-1 in Treating Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00031694 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
  
• Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00095966 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Doppler and Biological Second Trimester Placental Insufficiency Screening
  ClinicalTrials.gov Identifier: NCT00465634 - Active, not recruiting
  Pre-Eclampsia; Fetal Growth Retardation; Placental Insufficiency
  
• Phase I Study of Vaccination With MUC-1 Antigen and Immunologic Adjuvant SB AS-2 in Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00008099 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer
  
• Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00088894 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00078975 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00068432 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00114244 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003591 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage I pancreatic cancer; stage II pancreatic cancer
  
• Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005053 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without Pemetrexed Disodium in Treating Patients With Unresectable Stage II, Stage III, or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00049426 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; stage IVA pancreatic cancer; adenocarcinoma of the pancreas
  
• Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004884 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00432861 - Recruiting
  Cystic Fibrosis; Pancreatic Insufficiency
  
• Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00077519 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer
  
• Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00111904 - Recruiting
  stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00075452 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
  ClinicalTrials.gov Identifier: NCT00024362 - Active, not recruiting
  stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00058149 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• 3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas
  ClinicalTrials.gov Identifier: NCT00085371 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00024375 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003851 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas
  
• Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00066677 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00030732 - Active, not recruiting
  stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026338 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00010062 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00100815 - Active, not recruiting
  adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00023972 - Active, not recruiting
  stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003025 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas
  
• Screening For Early Pancreatic Neoplasia in Individuals With Familial Peutz-Jeghers Syndrome and in Relatives of Individuals With Familial Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00084357 - Active, not recruiting
  Pancreatic Cancer
  
• Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003780 - Active, not recruiting
  stage III pancreatic cancer; stage IV pancreatic cancer; Quality of Life; stage II pancreatic cancer
  
• Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003677 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00002955 - Active, not recruiting
  stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• SDCC - Prospective Cohort Study of Chronic Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00304148 - Active, not recruiting
  Renal Insufficiency, Chronic
  
• Study of the Efficacy and Safety of Glufosfamide Compared with Best Supportive Care in Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00099294 - Active, not recruiting
  Pancreatic Cancer
  
• Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004861 - Active, not recruiting
  stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003546 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer
  
• Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00112528 - Active, not recruiting
  duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003797 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease
  ClinicalTrials.gov Identifier: NCT00543933 - Recruiting
  Pulmonary Insufficiency
  
• BNP-Guided Diagnostic Strategy in ICU Patients with Respiratory Failure
  ClinicalTrials.gov Identifier: NCT00130559 - Active, not recruiting
  Respiratory Insufficiency
  
• Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00079365 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Convergence Insufficiency Treatment Trial (CITT)
  ClinicalTrials.gov Identifier: NCT00338611 - Recruiting
  Convergence Insufficiency; Binocular Vision Disorder
  
• Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
  ClinicalTrials.gov Identifier: NCT00010088 - Active, not recruiting
  adenocarcinoma of the extrahepatic bile duct; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; ...
  
• Cisplatin, Metronomic Low-Dose Interferon alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00082862 - Recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Safety and Efficacy of G17DT Immunogen in the Treatment of Advanced Pancreatic Carcinoma
  ClinicalTrials.gov Identifier: NCT00044031 - Active, not recruiting
  Pancreatic Cancer
  
• Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00323583 - Recruiting
  Adenocarincoma of Pancreas; Stage III Pancreatic Cancer; Stage IVA Pancreatic Cancer; Stage IVB Pancreatic Cancer
  
• Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00096070 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
  
• Study to Assess Bemiparin Pharmacokinetics in Renal Insufficiency and in the Elderly
  ClinicalTrials.gov Identifier: NCT00413088 - Recruiting
  Renal Insufficiency
  
• R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005832 - Active, not recruiting
  childhood gastrointestinal cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; ...
  
• Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00242190 - Active, not recruiting
  Pancreatic Neoplasms
  
• Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00064207 - Active, not recruiting
  adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer
  
• Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00006117 - Active, not recruiting
  stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• A Study to Test the Effectiveness of Virulizin® Given in Combination with Standard Chemotherapy for Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00040092 - Active, not recruiting
  Pancreatic Cancer
  
• An Investigational Drug in Patients with Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00095056 - Active, not recruiting
  Diabetes Mellitus, Type 2; Chronic Renal Insufficiency
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026403 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Aroplatin and Gemcitabine in Patients with Advanced Pancreatic Cancer Resistant to Standard Therapies
  ClinicalTrials.gov Identifier: NCT00081549 - Active, not recruiting
  Pancreatic Neoplasms
  
• Docetaxel in Combination with Iressa in Previously Treated Patients with Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00137761 - Active, not recruiting
  Metastatic pancreatic carcinoma
  
• Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003216 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
  
• Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003332 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• 6-Hydroxymethylacylfulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003760 - Active, not recruiting
  recurrent pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00075686 - Active, not recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Flavopiridol Plus Radiation Therapy Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00047307 - Recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer
  
• Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00510484 - Not yet recruiting
  Cystic Fibrosis
  
• Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00049348 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
  
• Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study
  ClinicalTrials.gov Identifier: NCT00100321 - Recruiting
  Pancreatic Neoplasms
  
• Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003029 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00005594 - Active, not recruiting
  stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00126633 - Active, not recruiting
  stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00112580 - Recruiting
  stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas
  
• Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026104 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Pilot Study Using Neoadj Chemo-Rad & EGFR-Tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00243854 - Recruiting
  Pancreatic Cancer
  
• Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00042939 - Active, not recruiting
  adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003049 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Biological Therapy in Treating Patients With Stage I, Stage II, or Stage III Pancreatic Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00003434 - Active, not recruiting
  stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003531 - Recruiting
  recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026130 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00307723 - Recruiting
  Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma
  
• Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00114179 - Active, not recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer; stage II pancreatic cancer
  
• Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00416507 - Active, not recruiting
  Pancreatic Cancer